ALKBH5 and hepatocellular carcinoma: Studies in hepatocellular carcinoma (HCC) and NSCLC have shown that tumor cell RNA modifications, such as those mediated by the N6-methyladenosine (m6A) demethylase ALKBH5, impact TAMs by regulating chemokine expression and thus affecting macrophage recruitment.